News
ChargePoint (CHPT -18.85%) shares have crashed because the market for electric vehicles is not growing as expected. *Stock prices used were the afternoon prices of July 17, 2025. The video was ...
ANGLE's Chief Scientific Officer, Karen Miller, commented: "We are proud to see ANGLE's technology increasingly being exploited to make novel discoveries into the biology of cancer, which may ...
CVS (CVS -1.63%) reported declining foot traffic to its retail stores in recent months. *Stock prices used were the afternoon prices of May 18, 2025. The video was published on May 20, 2025.
ANGLE provided CTC analysis with its Parsortix-based HER2 assay to assess breast cancer patients' HER2 (human epidermal growth factor receptor 2) status in a Phase 2 study of the HER2 targeting ...
This Perspective seeks to reconnect the current practice of nuclear magnetic resonance (NMR) spectroscopy in chemical structure and quantitative (qNMR) analysis with its roots in classical physics and ...
This letter proposes a novel analysis and design methodology for angle-stable frequency selective surface (ASFSS) based on high-order modes modulation. The theory of characteristic mode (TCM) is ...
Endor Labs Inc. says Microsoft Corp. has natively integrated its software composition analysis technology into its Microsoft Defender for Cloud cloud-native application protection platform. That ...
ANGLE's FDA cleared and patent protected CTC harvesting technology known as the Parsortix ® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic ...
ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE Option for exclusive licence to highly sensitive NGS assay for use with CTCs and dual analysis of CTCs with ctDNA Combining ...
Piramidal Inc. stepped into the limelight today, announcing that it has filled its war chest with $6 million in seed funding to tackle the intricacies of brainwave analysis using a specially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results